Malecare is the world's leading prostate cancer support group network. The "Prostate Podcast" is a interview show with Malecare's prostate cancer patient members and leading prostate cancer doctors and researchers. The Prostate Podcast presents the latest treatment information and patient centered discussion.
Prostate Cancer Podcast
Claim This Podcastby Malecare Cancer Support
4.0(16 reviews)
19 episodes
Updated Inactive
Accepts GuestsHas SponsorsLocation 🇺🇸
Podcast Overview
Malecare is the world's leading prostate cancer support group network. The "Prostate Podcast" is a interview show with Malecare's prostate cancer patient members and leading prostate cancer doctors and researchers. The Prostate Podcast presents the latest treatment information and patient centered discussion.
Language
🇺🇲
Publishing Since
5/13/2016
1 verified contact email on file for Prostate Cancer Podcast
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
July 24, 2018
Is Cyberknife a good prostate cancer treatment?
<p>Cyberknife is a robotic method of delivering radiation therapy. Listen to this 58 minute discussion about how radiation kills prostate cancer and whether Cyberknife is a good treatment for both local and advanced stage prostate cancer. Discussants are Seth Blacksburg, MD radiation oncologist from NYU/Withrop Medical Center in New York City and Darryl Mitteldorf, LCSW oncology social worker from Malecare Cancer Support https://malecare.org</p>
May 9, 2017
Digitalizing Your Biopsy - Whole Slide Imaging
<p>Digital Pathology...using computers to analyse your biopsy and create more accurate and safer diagnosis. <br /> Darryl Mitteldorf, LCSW from Malecare speaks with Russ Granzow and Esther Abels from Phips Digital Pathology Solutions</p>
December 5, 2016
Marijuana and Pain
<p>Can marijauna ease pain? How might marijauna help prostate cancer patients. Malecare Prostate Cancer http://malecare.org</p>
19 total episodes available
Deep-dive analytics for Prostate Cancer Podcast
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Prostate Cancer Podcast?
- How often does this podcast release new episodes?
This podcast updates inactive.
- Where can I listen to this podcast?
This podcast is available on 2 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.